ArticleOncotarget2020

Therapeutic applications of the selective high affinity ligand drug SH7139 extend beyond non-Hodgkin's lymphoma to many other types of solid cancers.

Rod Balhorn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.